Viewing Study NCT01311661

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 11:53 AM

Ignite Modification Date: 2025-12-31 @ 4:16 PM

Study NCT ID: NCT01311661

Status: COMPLETED

Last Update Posted: 2014-05-01

First Post: 2011-03-04

Is Gene Therapy: True

Has Adverse Events: True

Brief Title: A Study to Compare the Efficacy and Safety of Different Dosings of Olodaterol Administered With the Respimat® Inhaler in Patients With Moderate to Severe Asthma

Sponsor: Boehringer Ingelheim

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module